Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC

Specialties >>

Acute Myeloid Leukemia
Biosimilars
Bladder Cancer
Brain Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastric Cancer
Gastrointestinal Cancers
Genitourinary Cancers
Gynecologic Cancers
Head and Neck Cancers
Hematology
Hepatocellular Carcinoma
Immunotherapy
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Myeloproliferative Neoplasms
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Skin Cancers
Soft Tissue Sarcoma
Thyroid Cancers

Partners >>

Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up

Evolving Paradigms

2018  |  2017  |  2016  |  2015


Chronic Lymphocytic Leukemia


Cutaneous Squamous Cell Carcinoma


Role of Immunotherapy in NSCLC


Mantle Cell Lymphoma


Breast Cancer: Focus on CDK4&6 Inhibitors


Immunotherapy in Nonsquamous Non-Small Cell Lung Cancer


Non-Small Cell Lung Cancer


Soft Tissue Sarcoma


Clinical Advances in Prostate Cancer


Triple Negative Breast Cancer


CDK4&6 Inhibition


Pancreatic Cancer


BRAF-Mutant Melanoma


Sequencing Strategies in Prostate Cancer


Bladder Cancer


Immuno-Oncology: Checkpoint Inhibitors


Lymphoma


Squamous NSCLC


Gynecologic Cancer
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.